Navigation Links
AMIA on meaningful use: Invest in people and technology
Date:3/1/2011

AMIA, the association for professionals in biomedical and health informatics, sent comments to the federal Office of the National Coordinator on Health Information Technology (DHHS/ ONCHIT), which has actively supported and incentivized the adoption and meaningful use of electronic health records (EHRs) over the last year, and which solicited comment, through the HIT Policy Committee (HITPC), on the continuation of support for achieving meaningful use of EHRs in 2013 and 2014.

"We applaud the very rapid pace at which the HIT Policy and HIT Standards Committees have worked to advise the Department of Health and Human Services (DHHS) as it implements the electronic health record incentive program," said AMIA President & CEO Edward H. Shortliffe, MD, PhD, FACMI.

Dr. Shortliffe briefly summarized AMIA's position on EHR adoption and meaningful use. "AMIA strongly believes that three principles are essential to achieving meaningful use of certified EHR technology: 1) We must invest in people as well as technology; 2) Users need EHR systems that provide cognitive support and evidence-based functionalities; and 3) Adoption of EHR systems requires a balance of benefits and burdens that users will accept."

In a letter that accompanied AMIA's comments, Dr. Shortliffe stressed that the development of a true "meaningful use" pathway for EHRs "requires support of basic and applied informatics science to underpin and address issues of design safety, change implementation, error monitoring and reduction. A safe electronic platform that can improve healthcare delivery and quality requires investment in people across a broad range of expertise."

Further, AMIA states, "We believe that meaningful use criteria and quality measures should be carefully designed and tested to minimize the burden required to process and connect new pieces of information cognitively with the existing clinical record." AMIA members, who contributed to the organizational comments, are concerned that EHR- and EHR module-testing may fall short of ensuring that HIT systems reliably provide effective cognitive support to users in clinical settings. AMIA members would like to see systematic testing and evaluation that demonstrates achievement of meaningful use, interoperable health systems, and attainment of the desired effects on improved quality of care.

"Showing that a user can record, modify, and retrieve a single piece of information," said Dr. Shortliffe, "is very different from demonstrating that the EHR fully supports the user in applying that information in a way that meaningfully affects the delivery and quality of care."

AMIA provided a number of answers to specific questions about EHRs posed in the solicitation for comments, and stated its preference that meaningful use criteria specific to research should also be included in Stage 2, along with criteria specific to clinical care.

AMIA also recommended that the HITPC continue to consider options for Population Health / Public Health Criteria for Meaningful Use in an ongoing effort to advance quality outcomes and improvements.

"AMIA supports the ultimate goal of electronic case reporting from EHRs for public health reporting," added Dr. Shortliffe.


'/>"/>

Contact: Nancy Light
nlight@amia.org
301-657-5903
American Medical Informatics Association
Source:Eurekalert  

Related biology news :

1. Basque thesis investigates wide diversity within certain ovine, bovine and equine breeds
2. Europes R&D leaders assembled in Eilat agree to invest $46 million in joint R&D initiatives
3. U. Iowa team investigates function of junk DNA in human genes
4. Joshua E. Neimark Memorial Travel Assistance Award winners investigate stem cell transplantation, sustainable growth, women in academia, and conservation science
5. Measuring science investments
6. President Obama calls for increased investment in science, including biomedical research
7. Cancer Research Institute invests $450k in Oncovir to manufacture powerful immune stimulant
8. 7 CAMH scientists win Young Investigator awards focused on breakthrough research
9. Early investigations promising for detecting metastatic breast cancer cells
10. Researchers investigate why a limited number of white blood cells are attracted to injured tissue
11. American Association of Anatomists announces young investigator award winners
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
AMIA on meaningful use: Invest in people and technology
(Date:5/24/2016)... May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology ... LCD display is the latest premium product recently added to the range of products ... ... ... 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... DUBAI , UAE, May 9, 2016 ... choice when it comes to expanding freedom for high ... Even in today,s globally connected world, there ... online conferencing system could ever duplicate sealing your deal ... are obtaining second passports by taking advantage of citizenship ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , ... announced today the Clinical Reach Virtual Patient Encounter CONSULT module which enables ... the physician and clinical trial team. , Using the CONSULT module, patients and physicians ...
(Date:6/27/2016)...   Ginkgo Bioworks , a leading organism ... today awarded as one of the World Economic ... most innovative companies. Ginkgo Bioworks is engineering biology ... world in the nutrition, health and consumer goods ... customers including Fortune 500 companies to design microbes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita ... miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject of ... now. , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology: